Salivary biomarkers of obstructive sleep apnea syndrome in children

Francesca R Patacchioli1, Alessandra Tabarrini, Cristina M Ghiciuc

  • 1Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Pediatric Pulmonology
|January 30, 2014
PubMed

Insights

Children with obstructive sleep apnea (OSA) show altered hypothalamic-pituitary-adrenal (HPA) axis activity, indicated by increased salivary cortisol. This dysregulation may contribute to adverse health outcomes in pediatric OSA patients.

Area of Science:

  • Pediatric Endocrinology
  • Sleep Medicine
  • Neuroendocrinology

Background:

  • Obstructive sleep apnea (OSA) is prevalent in children and associated with various health issues.
  • The hypothalamic-pituitary-adrenal (HPA) axis and autonomic nervous system (ANS) are crucial for stress response and physiological regulation.
  • Dysregulation of these systems may play a role in the pathophysiology of pediatric OSA.

Purpose of the Study:

  • To evaluate HPA axis and ANS activity in children with mild or moderate-to-severe (MS) OSA.
  • To measure salivary cortisol and alpha-amylase diurnal patterns in pediatric OSA patients.
  • To correlate salivary biomarker concentrations with polysomnography (PSG) variables indicative of OSA severity.

Main Methods:

  • Pilot study involving 27 children with OSA (13 mild, 14 MS) and 7 healthy controls.
  • Collection of salivary samples to measure cortisol and alpha-amylase levels.
  • Enzyme-linked bioassays used for biomarker quantification.

Main Results:

  • Children with mild and MS OSA exhibited increased diurnal salivary cortisol production compared to controls.
  • The physiological circadian activity of the HPA axis was maintained in OSA children.
  • No significant changes in diurnal alpha-amylase trajectory or production were observed in OSA patients.
  • Morning salivary cortisol concentrations showed a negative association with disease severity in the MS OSA group.

Conclusions:

  • Pediatric OSA is linked to dysregulation of HPA axis activity.
  • Altered HPA axis function in children with OSA may contribute to the disease's adverse consequences.
  • Further research is warranted to explore the clinical implications of HPA axis dysregulation in pediatric OSA.
Abstract